T1	Participants 62 115	patients with implantable cardioverter defibrillators
T2	Participants 699 722	A total of 172 patients
T3	Participants 867 1016	majority of patients had a history of documented remote myocardial infarction and congestive heart failure New York Heart Association class II or III
